HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
fibraccel
Networked:
4
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
fibraccel: 4
Related Diseases
1.
Hemorrhage
08/20/1976 - "
Hemorrhage due to thrombocytopathies can in most cases be stopped by application of the homologous coagulation-active phospholipide complex Fibraccel, as shown in a study in which 78 patients suffering from various thrombocytopathies were checked.
"
01/01/1986 - "
[Effect and therapy in the control of thrombocyte-induced hemorrhage with phospholipids (exemplified by Fibraccel)].
"
2.
Blood Platelet Disorders (Thrombocytopathy)
08/20/1976 - "
Hemorrhage due to thrombocytopathies can in most cases be stopped by application of the homologous coagulation-active phospholipide complex Fibraccel, as shown in a study in which 78 patients suffering from various thrombocytopathies were checked.
"
3.
Epistaxis (Nosebleed)
05/30/1986 - "
[Local treatment of thrombocyte-induced epistaxis using Fibraccel].
"
4.
Spontaneous Platelet Aggregation
09/01/1988 - "
We were especially interested in the influence of Fibraccel on routine blood coagulation parameters: partial thromboplastin time (PTT), thrombin time (TT), prothrombin time = Quick fibrinogen, platelet count and activated clotting time, spontaneous platelet aggregation (alpha 2/Tr, platelet aggregation test II of Breddin), thrombelastography, blood loss from the chest drain, use of fresh frozen plasma, and side-effects of the substance after aortocoronary bypass grafting.
"
Related Drugs and Biologics
1.
Phospholipids (Phosphatides)
2.
Fibrinogen (Factor I)
Related Therapies and Procedures
1.
Therapeutics
2.
Coronary Artery Bypass (Coronary Artery Bypass Surgery)